MOACM
HRMY icon

Mutual of America Capital Management’s Harmony Biosciences HRMY Stock Holding History

Mutual of America Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,856
Closed -$206K – 1462
2023
Q2 		$206K Buy
+5,856
New +$202K ﹤0.01% 1402
2023
Q1 		– Sell
-6,216
Closed -$343K – 1468
2022
Q4 		$343K Buy
6,216
+331
+6% +$18.2K ﹤0.01% 1224
2022
Q3 		$261K Buy
5,885
+2,018
+52% +$98.4K ﹤0.01% 1284
2022
Q2 		$189K Buy
3,867
+582
+18% +$26.2K ﹤0.01% 1350
2022
Q1 		$160K Buy
3,285
+170
+5% +$6.93K ﹤0.01% 1417
2021
Q4 		$133K Buy
+3,115
New +$124K ﹤0.01% 1460

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Mutual of America Capital Management's HRMY Position: Q3 2023 in Review

Mutual of America Capital Management sold out of Harmony Biosciences (HRMY) in Q3 2023, closing a stake of 5,856 shares — an estimated $206K sold.

Mutual of America Capital Management first reported a position in HRMY in Q4 2021 and held it in 6 quarters. The position peaked at $343K in Q4 2022. 204 funds tracked by Wall St. Rank hold HRMY as of Q3 2023.

  • Mutual of America Capital Management reported no remaining Harmony Biosciences position as of Q3 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 5,856 Harmony Biosciences shares in Q3 2023, an estimated $206K.
  • Mutual of America Capital Management first reported a position in Harmony Biosciences in Q4 2021 and held it in 6 quarters.
  • Mutual of America Capital Management's Harmony Biosciences position peaked at $343K in Q4 2022.
  • 204 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2023.

Based on Mutual of America Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.